Literature DB >> 34711615

Reply: On Semiquantitative Methods for Assessing Vascular 18F-FDG PET Activity in Large-Vessel Vasculitis.

Mark A Ahlman, Roberto Maass-Moreno, Peter C Grayson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34711615      PMCID: PMC8805778          DOI: 10.2967/jnumed.121.263158

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  5 in total

1.  18 F-Fluorodeoxyglucose-Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis.

Authors:  Peter C Grayson; Sara Alehashemi; Armin A Bagheri; Ali Cahid Civelek; Thomas R Cupps; Mariana J Kaplan; Ashkan A Malayeri; Peter A Merkel; Elaine Novakovich; David A Bluemke; Mark A Ahlman
Journal:  Arthritis Rheumatol       Date:  2018-02-06       Impact factor: 10.995

2.  Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.

Authors:  Bruce D Cheson; Richard I Fisher; Sally F Barrington; Franco Cavalli; Lawrence H Schwartz; Emanuele Zucca; T Andrew Lister
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

3.  Comparing Semiquantitative and Qualitative Methods of Vascular 18F-FDG PET Activity Measurement in Large-Vessel Vasculitis.

Authors:  Himanshu R Dashora; Joel S Rosenblum; Kaitlin A Quinn; Hugh Alessi; Elaine Novakovich; Babak Saboury; Mark A Ahlman; Peter C Grayson
Journal:  J Nucl Med       Date:  2021-06-04       Impact factor: 10.057

4.  At Last, 18F-FDG for Inflammation and Infection!

Authors:  Richard L Wahl; Vasken Dilsizian; Christopher J Palestro
Journal:  J Nucl Med       Date:  2021-04-23       Impact factor: 10.057

Review 5.  FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.

Authors:  Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-11       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.